Oaktree Capital Group Sum‑of‑the‑Parts Valuation Analysis
Summary
The document contains only internal financial modeling data for Oaktree Capital Group, with no mention of political figures, government agencies, foreign actors, or potential misconduct. It offers no Provides SOTP valuation tables and fee‑related earnings multiples. Shows projected share price ranges under various conversion scenarios. Cites Morgan Stanley and Thomson Reuters data sources.
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Cannabis Investment Report – December 2017 Financial Metrics
The document is a financial summary of cannabis‑related public companies with valuation multiples and revenue figures. It contains no references to political figures, government agencies, foreign lead Provides LTM and forward revenue, EBITDA, and enterprise value for several cannabis firms. Lists stock tickers and market percentages for each company. Notes methodology for handling negative or extr
Bank of America Japan Investment Strategy Stock Ratings Table
The document is a routine analyst stock rating list for Japanese companies with no mention of influential political actors, financial misconduct, or controversial actions. It offers no actionable inve Lists buy-rated Japanese banks, insurers, and industrial firms as of November 2016. Analysts and market caps are provided, sourced from BofA Merrill Lynch. No references to government officials, fore
Bank of America Merrill Lynch European Dividend Yield Screen (Nov‑Dec 2016)
The document is a routine investment research note listing dividend‑yielding European stocks and a trading strategy. It contains no references to political figures, government agencies, financial misc Lists European banks, insurers and industrial firms meeting a dividend‑yield criteria. Describes a long position in SX5E 2018 dividend futures. Includes standard disclaimer about proprietary research
Morgan Stanley Research Report on Alternative Asset Manager Valuations
The document is a standard financial research note containing valuation analysis and scenario modeling for asset managers. It contains no references to political figures, government agencies, financia Discusses C‑corp conversion and fee‑related earnings re‑rating. Provides upside/downside scenarios and sensitivity analyses for several private‑equity firms. Includes appendices with valuation tables
Morgan Stanley Research KKR Sum‑of‑the‑Parts Valuation Exhibit
The document contains only internal financial modeling data for KKR with no mention of political figures, government agencies, foreign actors, or alleged misconduct. It offers no actionable investigat Provides upside/downside valuation scenarios for KKR's C‑corp conversion. Shows fee‑related earnings multiples and projected share price impacts. Cites Morgan Stanley and Thomson Reuters as data sour
UBS High Yield Corporate Bond Outlook – Spread Forecasts and Market Commentary
The document is a routine investment research note from UBS outlining bond spread expectations and market scenarios. It contains no references to influential political figures, government agencies, or Current US high‑yield spread at 660 bps, target 525 bps over six months. Positive scenario target 450 bps, negative scenario target 1,200 bps. Default rate projected to rise modestly to 3.5% by year‑
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.